LFWD official logo LFWD
LFWD 1-star rating from Upturn Advisory
ReWalk Robotics Ltd (LFWD) company logo

ReWalk Robotics Ltd (LFWD)

ReWalk Robotics Ltd (LFWD) 1-star rating from Upturn Advisory
$0.68
Last Close (24-hour delay)
upturn advisory logo
PASS
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock price based on last close icon Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • 1Y
  • 1M
  • 1W

Upturn Advisory Summary

12/12/2025: LFWD (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

Upturn 1 star rating for performance

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

1 star rating from financial analysts

3 Analysts rated it

Very few follow this stock; limited insights, higher-risk early investing.

1 Year Target Price $5.17

1 Year Target Price $5.17

Analysts Price Target For last 52 week
$5.17 Target price
52w Low $0.5
Current$0.68
52w High $4

Analysis of Past Performance

Type Stock
Historic Profit -46.58%
Avg. Invested days 21
Today’s Advisory PASS
Upturn Star Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 1.0
Stock Returns Performance Upturn Returns Performance icon 1.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 12/12/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 12.38M USD
Price to earnings Ratio -
1Y Target Price 5.17
Price to earnings Ratio -
1Y Target Price 5.17
Volume (30-day avg) 3
Beta 0.01
52 Weeks Range 0.50 - 4.00
Updated Date 12/14/2025
52 Weeks Range 0.50 - 4.00
Updated Date 12/14/2025
Dividends yield (FY) -
Basic EPS (TTM) -2.91

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Revenue by Geography

Earnings Date

Report Date 2025-11-18
When -
Estimate -0.205
Actual -0.19

Profitability

Profit Margin -121.82%
Operating Margin (TTM) -50.69%

Management Effectiveness

Return on Assets (TTM) -32.29%
Return on Equity (TTM) -127.95%

Valuation

Trailing PE -
Forward PE -
Enterprise Value 10662227
Price to Sales(TTM) 0.51
Enterprise Value 10662227
Price to Sales(TTM) 0.51
Enterprise Value to Revenue 0.44
Enterprise Value to EBITDA 1.04
Shares Outstanding 18293776
Shares Floating 17469524
Shares Outstanding 18293776
Shares Floating 17469524
Percent Insiders 1.86
Percent Institutions 4.65

About ReWalk Robotics Ltd

Exchange NASDAQ
Headquaters -
IPO Launch date 2014-09-12
President, CEO & Director Mr. William Mark Grant
Sector Healthcare
Industry Medical Devices
Full time employees 80
Full time employees 80

Lifeward Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals' post-stroke. The company markets and sells its products directly to institutions and individuals, as well as through third-party distributors. The company was formerly known as ReWalk Robotics Ltd. and changed its name to Lifeward Ltd. in September 2024. Lifeward Ltd. was incorporated in 2001 and is based in Yokneam Illit, Israel.